"The conference is amazing! I really enjoy how the conference improves over time as healthcare gets more advanced."
Industry-Leading Featured Speakers
HAS 21 Virtual will showcase well-known visionaries and C-level executives from leading healthcare organizations while providing an extraordinary virtual experience in Singapore, Dubai, and London. Key highlights include:
Day 1: Singapore
HAS 21 Virtual opens with a fireside chat with Head Coach of the Golden State Warriors and two-time NBA Coach of the Year, Steve Kerr. In addition, industry experts will share their outlooks on AI and clinical analytics, and two waves of breakout presentations will offer insights into increasing revenue, decreasing cost, improving quality, and more.
Day 2: London
Healthcare industry transformational leader and champion of social justice, Chris Chen, MD, CEO of ChenMed, and Brent James, MD, MStat, Clinical Professor, CERC, Department of Medicine at Stanford University School of Medicine, are the featured speakers for day 2. Former President of the American Medical Association Patrice Harris, MD, MA, American psychiatrist, will delve into health equity, and the live Analytics and AI showcases will feature data-related projects across a wide variety of vital topics.
Day 3: Dubai
An advocate for healthcare equity and innovation, featured speaker Amy Compton-Phillips, MD, president and chief clinical officer for Providence St. Joseph Health and CNN medical analyst, presents on day 3. Industry outlook speakers will explore financial analytics and life sciences anaytics, and two more waves of breakouts will share more critical experiences and learnings.
Steve is one of the pioneers in using analytics as a competitive advantage in the NBA and he will be sharing his learnings with our audience.
Beginning his seventh season as Head Coach of the Golden State Warriors, Steve Kerr has guided the club through five of the most prolific seasons in NBA history with a list of accomplishments that includes three NBA championships, five-straight NBA Finals appearances, the NBA’s single-season wins record (73), an NBA Coach of the Year award (2015-16), and five of the six winningest seasons in franchise history. He owns an overall playoff record of 77-28 (.733), the highest winning percentage among NBA head coaches all-time that have coached a minimum of 25 postseason games. On April 19, 2018 Kerr earned his 50th playoff victory in just his 65th game, accomplishing the feat in fewer games than any coach in NBA history.
In October 2018, Kerr was named as an assistant coach on the 2019-20 USA Basketball Men’s National Team. Kerr, along with Indiana Pacers Head Coach Nate McMillan and Villanova University Head Coach Jay Wright, join the staff of USA and San Antonio Spurs Head Coach Gregg Popovich to complete the USA National Team coaching staff. The coaches led the USA National Team in 2019-20, which included the 2019 FIBA World Cup in China (Aug. 31-Sept. 15, 2019) and the upcoming 2021 Summer Olympic Games in Tokyo, Japan. Kerr was a member of the USA Basketball team that captured the 1986 World Championship title in Madrid, the last American men’s senior team composed strictly of amateur players to capture a gold medal. A finalist for the 1988 U.S. Olympic Basketball Team, Kerr was also a member of the 1988 USA Select Team that finished 6-0 during a European tour.
Kerr, who won five NBA championships during a 15-year playing career, now owns eight championships as either a player or coach, becoming the first to win at least three NBA titles as a player and three as a coach. Kerr is just the third coach in NBA history to win three championships in his first four seasons at the helm, joining Phil Jackson (1991, 1992, 1993) and John Kundla (1949, 1950, 1952) as the only coaches to do so.
In the 2017 postseason, Golden State posted a 16-1 (.941) record, the best single-season playoff record in league history that included a playoff-record 15-game win streak. In Kerr’s first three seasons on the bench, the Warriors became the first team in NBA history to win at least 65 games in three consecutive campaigns (67, 73, 67).
In 2014-15, Kerr engineered the most successful campaign of any first-year coach in NBA history en route to Golden State’s first title in 40 years, posting a then-franchise-record 67 victories and establishing NBA records for most wins and highest winning percentage (67-15, .817) by a first-year head coach. The Warriors saw a 16-game improvement in 2014-15 over the previous season (51-31 in 2013-14), an NBA record for the biggest improvement by a 50-win team in league history. Kerr followed his inaugural campaign by winning the 2015- 16 NBA Coach of the Year Award for leading the Warriors to an NBA-record 73 regular-season wins in 2015-16 (73-9, .890), eclipsing the previous mark of 72 set by a Chicago Bulls squad in 1995-96 that featured Kerr in a reserve role. In addition to the single-season wins record, the Warriors set new league marks for single-season road wins (34), consecutive wins to begin a season (24), and consecutive regular-season home wins (54).
Originally named to the position on May 19, 2014, Kerr is the 25th head coach in franchise history and the 20th since the team moved to the West Coast in 1962. He is the fourth Warriors coach to win an NBA title, joining Eddie Gottlieb (1947), George Senesky (1956), and Alvin Attles (1975). He is also just the third coach in franchise history to be named Coach of the Year, joining Alex Hannum (1963-64) and Don Nelson (1991-92). Twice, Kerr and his coaching staff were named to coach the Western Conference All-Star Team (2015, 2017).
Kerr, 54, owns 30 years of NBA experience as a player, coach, television analyst, and front office executive, including a three-year stint (2007-10) as president of basketball operations and general manager for the Phoenix Suns. During his time as the Suns GM, the club posted a 155-91 (.630) record and earned a pair of playoff berths, including a trip to the 2010 Western Conference Finals.
Having made the playoffs 11 times during his playing career, Kerr is one of only 26 players in NBA history to win five championships, earning three rings with Chicago and two with San Antonio. A key reserve for Chicago during the team’s three-peat championship run from 1996-98, Kerr famously hit the game-winning, title-clinching shot in Game 6 of the 1997 NBA Finals. He won his fourth consecutive championship in 1999 with the San Antonio Spurs to become one of only two non-Boston Celtics to win four-straight NBA titles (joining Frank Saul, 1951-54). His fifth ring came in his second stint with the Spurs during his final NBA campaign in 2002-03.
The NBA’s all-time three-point percentage leader, having converted on 45.4 percent (726-of-1599) of his attempts from long range, Kerr amassed career averages of 6.0 points, 1.8 assists, and 1.2 rebounds in 910 regular season games with the Phoenix Suns, Cleveland Cavaliers, Orlando Magic, Chicago Bulls, San Antonio Spurs (twice) and Portland Trail Blazers.
Kerr was originally selected by the Phoenix Suns in the second round (50th overall) of the 1988 NBA Draft out of the University of Arizona, where he capped his collegiate career as a senior in 1988 by helping lead the Wildcats to their first Final Four appearance. An All-Pac 10 guard in both 1986 and 1988, he remains the school’s career leader in three-point field goal percentage (57.3 percent).
During his playing career, Kerr played for some of the most successful coaches in the history of the game, including Phil Jackson, Popovich, Lenny Wilkens, Cotton Fitzsimmons, and Lute Olson. Born in Beirut, Lebanon, and raised in Pacific Palisades, Calif., Kerr was a ballboy in 1978 and 1979 at UCLA, where his late father, Malcolm, was a professor.
As a broadcaster, Kerr has served two different four-year stints as a game analyst on TNT’s award-winning NBA coverage. In addition to a full slate of regular-season games, he also worked TNT’s marquee events, including the NBA All-Star Game, playoffs, and conference finals. During his most recent stint in broadcasting, beginning in 2010, Kerr also served as an analyst for NCAA Tournament and Final Four coverage on Turner Sports and CBS.
Kerr earned a degree in general studies from Arizona with an emphasis in history, sociology, and English in 1988 and advocates for gun control, supporting such organizations as the Brady campaign, Sandy Hook Promise, March For Our Lives, and Giffords. Kerr also helps fundraise for Oakland Promise, an initiative launched by Mayor Libby Schaaf and the Oakland Unified School District in 2016 that aims to triple the number of Oakland high school graduates who complete college by the year 2024. In October 2014, Steve and Margot Kerr committed $1 million to the University of Arizona to assist with the McKale Memorial Center renovation and future academic facility enhancements.
Born on September 27, 1965, Steve and his wife, Margot, have two sons, Nicholas and Matthew, and one daughter, Madeleine. Nick received his degree from the University of San Diego in 2015 and completed his graduate studies at the University of California, Berkeley, where he played as a walk-on for the Bears’ basketball team for one season. Nick is now an assistant video coordinator for the Warriors. Madeleine received her degree from UC Berkeley, where she was a member of the volleyball team, as is now a second-year law student there. Matthew is a senior at the USC School of Cinematic Arts.
Join our fireside chat with Steve Kerr as he shares many of his life experience insights, including:
What it was like to represent the US at the recent Olympics, including preparing a team that didn’t come fully together until the day of the first game.
How his international upbringing prepared him to coach and mentor a diverse talent of NBA team members.
How analytics has shaped the NBA, how he and his coaches rely increasingly on analytics to shape their daily and season strategies, and what types of analytics-driven insights have proven most helpful.
Chief Analytics and Data Science Officer, Health Catalyst
Jason Jones is passionate about achieving the Quadruple Aim through better and easier use of data in healthcare, including helping organizations to find analytic focus; helping providers feel that the systems they work for have their backs; and helping people to understand and have their goals and preferences respected for the hopefully brief periods during which they are “patients.” Previously, Jones served as Vice President, Information Support for Care Transformation, at Kaiser Permanente (KP). In that capacity, he brought together and co-led the national Hospital and Healthplan Quality and Finance analytic functions and led development of national quality strategy and care delivery IT investments. Prior to that, he was KP’s Executive Director of Clinical Intelligence and Decision Support and a Research Scientist in KP’s Southern California region. Before joining KP, Jones was a Senior Medical Informaticist for Intermountain Healthcare. He also held analytic and marketing positions at Bayer Healthcare in Wayne, N.J., and Ingenix (now Optum) Pharmaceutical Information Products in Salt Lake City, where he developed a model for converting United Healthcare data into a saleable asset for external customers conducting outcomes research. Throughout his career, Jones has taught graduate courses in statistics to medical informaticists at the University of Southern California and at the University of Utah. He has published dozens of peer-reviewed papers in medicine, predictive modeling, and outcomes improvement.
For the last significant leadership decision you participated in, did you use any statistical, AI, or machine learning techniques? Augmented AI analytics are coming in healthcare, they are critical, and they are achievable. Augmented AI analytics are like an X-ray you can apply to your existing analytics to gain much better and deeper insight.
Jason will conduct a live demo where the audience can participate live and personally interpret data as shown in traditional BI tools. And then see a demo of the same data with augmented AI analytics applied visually to the same data set. The audience will determine for themselves whether their original interpretations were correct or incorrect. And then imagine applying this to any recent decision made based on typical BI-driven data analytics.
Gartner has said that analytics and BI platforms are no longer differentiated by their data visualization capabilities but by how well platforms support augmented analytics. Augmented AI analytics are coming and are achievable. How prepared are you for this shift?
Chief Clinical Officer, Senior Vice President and General Manager, Clinical Quality Analytics, Health Catalyst
Holly Rimmasch serves as the Chief Clinical Officer and SVP & GM, Clinical Quality Business Unit at Health Catalyst. She brings more than three decades of healthcare experience to her role, ranging from direct patient care to clinical and operational healthcare strategy and management. Key areas of accountability include clinical improvement, patient safety, quality, and population health.
Prior to joining Health Catalyst, she had many roles including the role of the Assistant VP at Intermountain Healthcare responsible for Clinical Services and the system Clinical Operations Director for Cardiovascular and Intensive Medicine. At Intermountain and Health Catalyst, Holly has held leadership roles enabling her to affect change at a system level. Holly also co-founded and was a Principal in HMS, Inc, a healthcare strategic consulting firm focusing on population health.
She has spent the last 25 years dedicated to identifying opportunities through data and analytics, implementing best practices, supporting adoption, and improving clinical, operational and financial outcomes. Holly holds a Master of Science in Adult Physiology from the University of Utah and a Bachelor of Science in Nursing from Brigham Young University.
Our task is to create a highly reliable system focused on the highest quality and safety that allows rapid response to new opportunities and emerging threats. While the concept of a high-reliable system was introduced in 2001, we haven’t made enough progress to that goal. Holly will discuss the best practices for high-reliability organizations including
Set a goal to be a high-reliability organization
Bolster your culture (culture matters)
Gather information (from multiple sources), integrate into daily operations, and close gaps
Technology Speaker, Founder of Robogals, Aipoly, and Aubot
Forbes 30 Under 30 roboticist and entrepreneur, Marita Cheng inspires people to lead through technology. While studying engineering at university, Marita founded Robogals, a global organization that inspires girls into engineering careers and tertiary studies through teaching girls robotics. For her work with Robogals, she was named the 2012 Young Australian of the Year and received an Asia Society Game Changer Award at the United Nations! Through attending Singularity University’s 10-week Graduate Studies Program, Marita founded Aipoly, using AI to recognize objects in real time to help the visually impaired navigate the world, winning a CES Best of Innovation Award two years in a row! And then Aubot, where she currently serves as CEO, making telepresence robots and robotics arms that care and enable. Named one of Forbes World’s Top 50 Women in Tech and the youngest Member of the Order of Australia, Marita shows there are no limits.
These are actual headlines from national Australian newspapers. Learn how Marita Cheng went from a small-town girl living in government housing to conquering the globe as one of Forbes Top 50 Women in Tech in the World, and the second youngest person to become a Member of the Order of Australia (like a junior knighthood). Noticing the limited number of girls in her engineering class, at the age of 19, Marita founded Robogals to inspire girls into robotics, growing the organization into an international movement. She followed that up with artificial intelligence company Aipoly to help the blind identify objects in real-time, which resonated with millions of people. And robotics company Aubot, making robots to help people in their everyday lives. Hold on tight as pocket rocket Marita shares how she changed the world.
Key Takeaways:
The only failure is failure to try
Do your best at what’s in front of you, and more opportunities will present themselves
Executive Vice President, Chief Analytics Officer, Community Health Network
Patrick McGill serves as the Executive Vice President, Chief Analytics Officer. In this capacity, he provides oversight for the Office of Network Analytics and Analytics Center of Excellence. In addition to Analytics, he leads Information Technology, Clinical Informatics, Process Improvement, Business Process Center of Excellence, Patient Experience analytics, and Regulatory Reporting. Most recently, he served as the Senior Vice President for Clinical Strategy, leading the Product Lines in the reduction of clinical variation, strategies for growth, and success in value-based care. Prior, he served as the Vice President of Clinical Transformation leading clinical improvement activities. Furthermore, Dr. McGill has special interests in digital transformation, process automation, advanced clinical analytics, clinical decision support, office workflow efficiency, and waste reduction.
Born and raised outside of Atlanta, Georgia, Dr. McGill attended the University of Georgia in Athens, Georgia, graduating with a Bachelor of Science in Chemistry. He received his medical degree from the Medical College of Georgia in Augusta, Georgia, and completed his residency at Ball Memorial Hospital in Muncie, Indiana. Prior to joining Community Physician Network in 2010, he practiced Family Medicine in Pendleton, Indiana, and has experience in Emergency and Urgent Care medicine. He is board certified in Family Medicine and continues to see patients at South Indy Family Practice.
As the number of employed physicians climbs, even exceeding those in private practice (2018 AMA), ambulatory practice management is an area of increasing difficulty at nearly every health system. Manual and siloed reporting and lack of governance can cause incredible waste.
Learn how CHNw, a health system with more than 200 sites of care and a $300M investment in physician practices, tackled this problem by developing a comprehensive practice management application comprising modules for each reporting area: panel management, access, productivity, quality, patient satisfaction, and staffing/practice services. Improvements included reduction of 2 FTEs (for manual reporting) and improved panel management with early identification of patients falling off panels.
Participants will discover:
Why operational engagement is critical and why analytic insights are not intuitive to operational leaders.
What takes the most time in application development for systemic improvement.
Why mobile development is key to adoption and utilization of a management application.
Public Health Physician, Professor, and Health Policy Expert
Vin Gupta, MD, MPA, MSc, is an Affiliate Assistant Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
Clinically active as a Pulmonary/Critical Care physician, Dr. Gupta’s research has focused on several important issues in global public health. He previously was a full-time Assistant Professor with the Institute for Health Metrics and Evaluation (IHME) and the Department of Health Metrics Sciences (HMS) from 2018-2020. During this time, Dr. Gupta helped lead a large research portfolio examining the global burden of non-communicable diseases using the most advanced epidemiologic methods. These efforts were primarily funded by Bloomberg Philanthropies and focused on attributable disease from tobacco use globally, with particular focus on Mexico, Brazil, China, and Indonesia. A secondary area of focus included assessing the impact of environmental health considerations (e.g., air pollution) on chronic respiratory disease.
He concurrently holds active commissioning as Major in the United States Air Force Reserve Medical Corps, where he serves a deployable critical care aerospace physician with the 446th Aeromedical Staging Squadron based at Joint-Base Lewis McChord.. In this capacity, Dr. Gupta previously assisted with bolstering the emergency health crisis response capabilities of partner nations in Africa as part of the US State Department’s African Peacekeeping Rapid Response Partnership (“A-Prep”) initiative.
In his current role as Principal Scientist at Amazon, Dr. Gupta provides clinical and strategic leadership to the company’s internal and external COVID-19 response work, including overseeing the funding of clinical trials, expanding its work in public health through community-based initiatives, and ensuring the implementation of evidence-based workplace health and safety protocols.
Dr. Gupta received his BA from Princeton, MD from Columbia University’s Vagelos College of Physicians & Surgeons, Master’s in International Relations from the University of Cambridge, and Master’s in Public Administration from the Kennedy School of Government at Harvard. He is a term member of the Council on Foreign Relations, regular health policy contributor for national media outlets, and board member on several health-focused nonprofit organizations nationwide.
Dr. Gupta will talk about the four pillars of Healthcare Delivery in the future.
The Data Revolution: aggregating and interpreting data and using machine learning and AI will allow for improved and targeted health offerings, bolstering wellness and retention
Behavior Change: virtual care is here to stay with more frequent touchpoints, lower costs, and better care.
Productizing Healthcare Delivery: at-home devices and diagnostics have shifted the product environment away from a singular focus on wellness to prevention.
Transforming Communications: the consumption of health information is shifting from traditional vehicles to new vehicles like social media. The way we communicate must adapt and change in parallel
American psychiatrist, Former President, American Medical Association
Dr. Patrice A. Harris is board-certified in psychiatry and has diverse experience as a private practicing physician, public health director and patient advocate. In 2019, Dr. Harris was elected as the 174th President of the American Medical Association, the first African-American woman to ever hold the position.
Dr. Harris’ life is marked by her passion to improve the lives of children and communities around her, especially communities of color. She is a recognized expert in children’s mental health and childhood trauma, leading both local and national efforts to integrate public health, behavioral health and primary care services. She has received numerous awards in recognition of her service and leadership.
Upon completing her term as President of the AMA, Dr. Harris has continued in private practice. She regularly consults with public and private organizations on health service delivery and emerging trends in health policy. She is a Visiting Professor at Columbia University, an Adjunct Professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine and an Adjunct Clinical Assistant Professor in Psychiatry and Behavioral Sciences at Morehouse School of Medicine. Dr. Harris is a Fellow of the American Psychiatric Association.
Dr. Harris will share many insights on health equity, based on her years of experience. She will define health equity as having the conditions, resources, opportunities, and power to achieve optimal health. She will share a public health framework for health equity, including social inequities, institutional inequities, living conditions, risk behaviors, disease and injury, and mortalities. And key opportunities for engagement including strategic partnerships, community organizing, civic engagement, health education, case management, healthcare, and public policy.
She will also share her perspective on the reasons for the unequal impact of COVID for communities of color, and she will advocate that words really matter, with equality and often well-intended concepts but not always grounded in our current reality or leading to justice as an ultimate goal.
Supporting all of these concepts will be her repeated requests for data to help identify and bring evidence and context to light, supporting intellectually honest conversations that can turn data into action.
Industry leader. Transformational innovator. Champion of social justice. Christopher Chen, M.D. is leading a healthcare revolution through the family-owned company that bears his name.
Dr. Chen is the Chief Executive Officer of ChenMed; a physician-led healthcare practice that is changing the lives of low- and moderate-income seniors managing multiple, complex conditions through a concierge-style, value-based care model that produces 30-50 percent fewer hospitalizations compared to standard primary care.
Since becoming ChenMed’s CEO in 2009, Dr. Chen has been on a quest to turn ChenMed into America’s leading primary care provider, transforming care of the neediest populations. He has created a highly scalable, technology-driven approach, and has grown the company more than 30 percent per year. Today, ChenMed boasts more than 75 medical centers in 10 states.
ChenMed’s innovative approach fixes the perverse incentives of fee-for-service to align with patient well-being by taking prospective payment and full accountability for the quality, service, and total cost of care. The care model focuses on prevention, wellness, accountability, and reducing negative variability.
This approach has earned praise from the White House, the Department of Health and Human Services, the U.K. National Health System, and publications such as Modern Healthcare, Health Affairs, Forbes, and The Economist. In addition, Medical Economics named ChenMed “Best Primary Care System in the U.S.,” and Fortune listed ChenMed as the only health care delivery organization on its 2020 list of companies that are “changing the world.”
Brought up in South Florida, Dr. Chen graduated from the University of Miami’s Honors Program in Medicine. He went on to complete his medical training at Beth Israel Deaconess, a Harvard University teaching hospital, after which he completed a fellowship in cardiology at Cornell University Medical College in Manhattan, New York. A board-certified cardiologist, Dr. Chen sees patients at the company’s Miami Gardens, Florida medical center.
Brent C. James, MD, MStat -
Clinical Professor, Clinical Excellence Research Center (CERC), Department of Medicine, Stanford University School of Medicine
Clinical Professor, Clinical Excellence Research Center (CERC), Department of Medicine, Stanford University School of Medicine
Brent James is known internationally for his work in clinical quality improvement, patient safety, and the infrastructure that underlies successful improvement efforts, such as culture change, data systems, payment methods, and management roles.
He is a member of the National Academy of Medicine (formerly known as the Institute of Medicine), and participated in that organization’s seminal works on quality and patient safety.
He is a Clinical Professor at the Clinical Excellence Research Center (CERC), Department of Medicine, Stanford University School of Medicine.
He holds adjunct faculty appointments at several other universities:
Visiting Lecturer, Harvard School of Public Health (Health Policy and Management)
Adjunct Professor, University of Utah David Eccles School of Business
Adjunct Professor, University of Utah School of Medicine (Family Medicine; Biomedical Informatics)
He is a Fellow of the American College of Physician Executives.
He is presently a Senior Advisor at Health Catalyst, Salt Lake City, UT; Senior Fellow at the Institute for Healthcare Improvement (IHI), Boston, MA; and a Senior Advisor at the Leavitt Group, Salt Lake City, UT.
He is was formerly Chief Quality Officer, and Executive Director, Institute for Healthcare Delivery Research at Intermountain Healthcare, based in Salt Lake City, Utah.
Through the Intermountain Advanced Training Program in Clinical Practice Improvement (ATP), he has personally trained more than 5,000 senior physician, nursing, and administrative executives, drawn from around the world, in clinical management methods, with proven improvement results (and leading to over 50 “sister” training programs in more than 10 countries).
He currently anchors an upgraded version of the ATP, Mastering Clinical Quality / Leading Clinical Change (MCQ), based at Health Catalyst in Salt Lake City, UT.
He has been honored with a series of awards for quality in health care delivery, including (among many):
2018 John M. Eisenberg Patient Safety & Quality Individual Award, Joint Commission & National Quality Forum, March 2019
Distinguished Alumnus, University of Utah, 2015
Deming Cup – Columbia University School of Business, 2011
C. Jackson Grayson Medal, Distinguished Quality Pioneer – American Quality and Productivity Center, 2010
Joint Commission Ernest A. Codman Award, 2006
AHA HRET TRUST Award, 2005
National Committee for Quality Assurance (NCQA) Quality Award, 2005
American College of Medical Quality Founders’ Award, 1999
For 8 of first the 9 years it existed, he was named among Modern Physician’s “50 Most Influential Physician Executives in Healthcare.” He was named among the “100 Most Powerful People in Healthcare” (Modern Healthcare) for over 5 consecutive years, and among Modern Healthcare’s “25 Top Clinical Informaticists”.
Before coming to Utah in 1986, he was Assistant Professor in the Department of Biostatistics at the Harvard School of Public Health, providing statistical support for the Eastern Cooperative Oncology Group (ECOG) and Cancer & Leukemia, Group B (CALG); and staffed the American College of Surgeons’ Commission on Cancer.
He holds the following degrees; Bachelor of Science degrees in Computer Science (Electrical Engineering) and Medical Biology; an M.D. degree (with residency training in general surgery and oncology); and a Master of Statistics degree.
He serves on several non-profit boards of trustees dedicated to clinical improvement and patient safety.
ChenMed is a physician-led practice built around serving low-income, underserved Medicare Advantage seniors through a concierge-style, value-based care model. This model dramatically improves the quality of care and outcomes in a compassionate and coordinated way, producing 30-50 percent fewer hospitalizations compared to standard primary care. ChenMed operates a fully capitated model which fixes the perverse incentives of fee-for-service to align with patient well-being by taking prospective payment and full accountability for the quality, service, and total cost of care. The care model focuses on prevention, wellness, accountability, and reducing negative variability. Join us to hear about how ChenMed has a created a viable, sustainable, replicable, and scalable value-based care model.
Dr. Anthony Lee David Sanders was born and raised in Aurora, IL, to Mark and Monica Sanders. He is the youngest of four children. He went to Fisk University in Nashville, TN, where he received his BA in biology and became a member of the distinguished Alpha Phi Alpha Fraternity, Incorporated. He subsequently went to Meharry Medical College where he received his medical doctorate in 2005. Upon graduation from medical school, he moved to Indianapolis, IN, to complete his residency training in Obstetrics and Gynecology at Indiana University School of Medicine. Since graduation from residency in 2009, he has been practicing Obstetrics and Gynecology with Community Health Network at Community Hospital East in Indianapolis, where he serves the underserved population. In 2016, he started a comprehensive program focused on treating substance use disorders with a focus on opioid addiction in pregnancy which has progressed to treat all substance use disorders during pregnancy and the postpartum period. His passion for serving the underserved goes beyond the borders of the United States. He first started going on medical mission trips in 2004 to Zimbabwe and now typically goes on medical mission trips multiple times per year. In addition to Zimbabwe, his missionary travels have taken him to Ghana, Liberia, Nigeria, El Salvador, and Haiti. Dr. Sanders and his wife since 2006, Dr. Alicia Sanders, have been blessed with 3 beautiful children, Sydney, Victoria and Anthony the 2nd.
Alexandra Wroe, MBA, BScN, RN, ACM-RN -
Director of Care Coordination, Utilization Management and Clinical Documentation Improvement, The Queen’s Medical Center
Director of Care Coordination, Utilization Management and Clinical Documentation Improvement, The Queen’s Medical Center
Alex Wroe is the Director of Care Coordination, Utilization Management and Clinical Documentation Integrity at the Queen’s Medical Center where she leads at team focused on reducing length of stay, promoting patient flow and readmission prevention. She also specializes in addressing social determinants of health and capturing an accurate clinical record for optimized reimbursement and quality reporting.
Alex worked as an emergency room nurse before starting her journey in care coordination. She is passionate about care transitions, addressing health disparities and motivated to improve quality patient outcomes while decreasing total cost of care as patients move through the care continuum.
Alex has an undergraduate degree in nursing from Laurentian University in Ontario, Canada and a Master’s in Business Administration from The University of Ottawa. With over 10 years of experience in the healthcare industry in Canada and the United States, Alex is continuously working with internal and external stakeholders to challenge the status-quo and bring meaningful change to healthcare and the local community.
Chief Analytics and Data Science Officer, Health Catalyst
Jason Jones is passionate about achieving the Quadruple Aim through better and easier use of data in healthcare, including helping organizations to find analytic focus; helping providers feel that the systems they work for have their backs; and helping people to understand and have their goals and preferences respected for the hopefully brief periods during which they are “patients.” Previously, Jones served as Vice President, Information Support for Care Transformation, at Kaiser Permanente (KP). In that capacity, he brought together and co-led the national Hospital and Healthplan Quality and Finance analytic functions and led development of national quality strategy and care delivery IT investments. Prior to that, he was KP’s Executive Director of Clinical Intelligence and Decision Support and a Research Scientist in KP’s Southern California region. Before joining KP, Jones was a Senior Medical Informaticist for Intermountain Healthcare. He also held analytic and marketing positions at Bayer Healthcare in Wayne, N.J., and Ingenix (now Optum) Pharmaceutical Information Products in Salt Lake City, where he developed a model for converting United Healthcare data into a saleable asset for external customers conducting outcomes research. Throughout his career, Jones has taught graduate courses in statistics to medical informaticists at the University of Southern California and at the University of Utah. He has published dozens of peer-reviewed papers in medicine, predictive modeling, and outcomes improvement.
Director Community Health Programs, Parkland Health & Hospital System
Teresita Oaks serves as Parkland’s Director of Community Health Programs and in this role she is responsible for the execution of Parkland’s triennial Community Health Needs Assessment (CHNA) and its implementation plan.
Teresita Oaks has over 20 years of health equity experience, both at the national and international level and has devoted her career to improving the overall health of traditionally underserved individuals and communities. Her initial work in refugees’ camps, in Central America on behalf of the International Red Cross and serving migrant farmworkers in rural Arizona, sparked her interest in social justice and health equity. With the lessons learned in the field, coupled with academia, Teresita instituted Community Based Participatory Research as a vehicle to include community members in all levels of decision making in the Arizona department of Health Services where she served as the strategic planner of a $2B project aimed at reducing 25 year mortality gap for individuals with a serious mental illness diagnosis.
Teresita is also responsible for establishing Aetna Medicaid’s health equity program and in her present role she leads the efforts of the Dallas County CHNA and its Implementation Plan by convening a series of internal and external stakeholders through Collective Impact to work together for common goals. The CHNA serves as the foundation for Dallas County’s COVID 19 testing and vaccination strategies.
Chief Diversity, Equity & Inclusion Officer, Health Catalyst
Trudy Sullivan leads Diversity & Inclusion efforts as a Health Catalyst leadership team member. She holds a Masters in Business Administration from Kellogg School of Management at Northwestern University, and a BA in History from the University of Portland, Oregon. Sullivan brings experience in B2B, B2C + B2G environments, from innovative high tech companies, including biomedical, semiconductor and aerospace & defense. She spent more than a decade in healthcare, including serving more than one hundred Pacific Northwest hospital customers, as CEO of an American Red Cross blood services region. Sullivan’s functional experience includes Operations Management; Human Resources; Marketing; Business Development; Strategy; M & A; Investor, Government + Community Relations; and Brand Development.
Join Trudy Sullivan as she will facilitate a panel discussion with four leaders who are starting down the journey of using data to identify and address health equity disparities. The panel members include:
Dr. Anthony Sanders, Physician – OBGYN, Community Health Network
Teresita Oaks, MPH – Director, Community Health Programs, Parkland
Alexandra Wroe, Director, Care Coordination, UM & CDI, Queens Medical Center
Jason Jones, Chief Analytics and Data Science Officer, Health Catalyst
Will Caldwell attended Davidson College where he prepared for a career in medicine, studying biology and working in East Africa as a wildlife manager. Dr. Caldwell completed residency training in otolaryngology – head and neck surgery at the University of Maryland Medical System and the Shock Trauma Center of Maryland. He went on to achieve triple board certification in otolaryngology, allergy and immunology, and sleep medicine. In 2013, he became a board member and medical director of Give Hope Global, a not-for-profit entity dedicated to the development of health systems focused on the use of community health workers. He also serves as Senior Medical Advisor to Zanmi Lasante, the name for Partners in Health in Haiti. His work was documented in a film which won two Emmy Awards. Dr. Caldwell earned his MBA With Highest Honors and was named for Academic Distinction from Wake Forest University. He served as the Senior Vice President for Clinical Integration at Novant Health, building the Novant Health Clinically Integrated Network, a value-based platform comprised of over 2800 providers across 26 specialties. In his current role as Senior Vice President for Physician and Market Development at Health Catalyst, he promotes the use of data analytics to promote good health and save lives. His area of expertise rests in technology-enabled healthcare delivery models and value-based care platforms. He continues to see patients and has received over 26 awards for clinical excellence during his 17-year career as a clinician.
After years of saying value-based care is coming, Dr. Caldwell will make the case that emerging trends are enabling the true shift to population health. He will:
Create excitement about your role in helping others live healthier lives.
Raise awareness of the opportunity facing us.
Understand the role that private equity is playing.
Encourage us to rethink how we source and use data.
Move from disease management to population health management.
Understand the largest unrealized opportunity in managing the total cost of care and driving better outcomes.
President, Clinical Care at Providence St. Joseph Health
Amy Compton-Phillips, M.D., is an internationally respected healthcare executive, innovator, speaker and author serving as president and chief clinical officer for Providence. She is responsible for improving health, care, and value outcomes delivered by the 51 hospitals, 800+ clinics, and 120,000 caregivers of the $25 billion health system. In January 2020, Dr. Compton-Phillips led treatment of the first confirmed case of Covid-19 in the United States.
A CNN medical analyst, Dr. Compton-Phillips is a vocal advocate for equity and innovation in healthcare. She has been instrumental in Providence’s early adoption and scaling of technology including telehealth, data analytics and artificial intelligence solutions that are critical to the system’s pandemic response and the future of healthcare.
Dr. Compton-Phillips serves as a director on the boards of the Healthcare information and Management Systems Society (HIMSS), the Institute of Systems Biology, Lumedic, Multiscale Health Networks, and chairs the High-Value Healthcare Collaborative.
Before joining Providence in 2015, Dr. Compton-Phillips served 22 years at Kaiser Permanente. She began as a front-line internist, and through a succession of roles spent her last years there as a chief quality officer. Her main focus was on improving healthcare value at scale.
Dr. Compton-Phillips holds a bachelor’s degree from Johns Hopkins University and earned her medical degree from the University of Maryland School of Medicine. She is a board-certified internist with strong interests in innovation and wellness.
In April 2020, Providence realized that they were going through a threshold moment because of the pandemic. They found inspiration in the following quote:
“Historically, pandemics have forced humans to break with the past and imagine their world anew. This one is no different. It is a portal, a gateway between one world and the next. We can choose to walk through it, dragging our… prejudice…our data banks and dead ideas…behind us. Or we can walk through lightly, with little luggage, ready to imagine another world. And ready to fight for it.” Arundhati Roy, “The Pandemic Portal.”
Amy will share how Providence has been using data and information to change, drive, and accelerate into the future because of the things they have had to do very rapidly in the past 18 months.
Senior Vice President and General Manager, Financial Transformation Business, Health Catalyst
Dan Unger joined Health Catalyst in April 2014 and serves as the SVP and General Manager of Financial Transformation Business. He came to Health Catalyst after working at R1 RCM where he managed a consulting team that worked with large health systems to improve revenue cycle processes and reduce costs through analytics and operational improvements. Prior to R1, Dan worked as a consultant at Equation Consulting, a physician economics consulting firm, and as a pricing and profitability analyst at JP Morgan Chase. He graduated from the University of Arizona with degrees in Finance and Entrepreneurship and received his MBA in International Finance from the Thunderbird School of Global Management.
We have a business problem in US Healthcare – not a technology or care problem. And the business problem is squarely centered on providers. We have large healthcare ecosystems that are growing faster than providers and new innovative models (vertically integrated insurers, innovative care entities, and large corporations) targeting provider revenue. And most healthcare systems are playing prevent defense.
But healthcare providers have significant assets and advantages they have not fully realized or operationalized yet. And this presents an opportunity for shifting the role of the CFO and finance team. More can step up as strategic leaders, build relationships and move from traditionally insular to more collaborative roles. We can move from playing defense to playing to win.
In this presentation, Dan will cover four topics, including
Understanding the changing competitive landscape in healthcare.
Defining a new role for healthcare finance leaders.
Identifying new skills finance teams need.
Learning how health systems can use data to win in this new world.
General Manager & Senior Vice President, Life Sciences Business, Health Catalyst
Sadiqa Mahmood, DDS, MPH is the Senior Vice President and General Manager of the Life Sciences business at Health Catalyst and contributes to the overall vision and growth for the company. Sadiqa’s work focuses on identifying and addressing areas of high unmet need for therapeutic development through application of real-world data. She is an advisor to several healthcare organizations and global policy makers. Sadiqa is a dental surgeon and holds a master’s degree in public health from the Harvard School of Public Health.
Passionate about improving access to care and patient outcomes by leveraging data and healthcare ecosystem, Sadiqa has spent her career at the intersection of medicine, policy, technology, and analytics. Previously she led clinical analytics, quality and safety, value-based contracting, and population health across healthcare organizations, including the Dana-Farber Cancer Institute, Partners HealthCare System, and Boston Medical Center. Sadiqa has been an advocate of collaborative learning system in healthcare and has steered cross-industry multi-stakeholder national and global collaborations to drive healthcare innovation.
She joined Health Catalyst in 2019 as SVP of Medical Affairs. Sadiqa has lived and worked in Asia and UK in addition to the US. She is based in Boston, Massachusetts. Outside of work, she is a Formula 1 fan and races as a member of a local team.
Sadiqa Mahmood will talk about the latest trends that define clinical research and how they are changing how providers and pharma work together to leverage technology and data. She will assert that to execute on the promise of clinical research, you need a role model to:
Improve the quality of data and subsequent insights.
Sadiqa will make the case that high-value information and high-value cross-industry collaboration pillars will enable a new level of treatment options and better care.
Even if you are not directly involved in research, Sadiqa will share and invite you to consider the benefits and value that clinical research-related activities could bring value to your organization.
Co-Founder and CEO, Affectiva, Pioneer and Inventor of Emotion and Human Perception AI
What if our high-tech devices could decipher and respond to our every action and feeling? Rana el Kaliouby, Ph.D., is on a mission to humanize technology with artificial intelligence (AI) that understands not just our commands but our facial expressions, body language and emotional states, or what she calls “Human Perception AI.” She envisions and works to create a world where devices and technologies that once separated us will bring us together. It’s the next frontier in AI, with commercial applications across industries – and it’s closer than we think.
A computer scientist, technologist, entrepreneur and business leader, Dr. el Kaliouby believes that “humanizing technology gives us a golden opportunity to reimagine how we connect with machines, and, therefore, how we connect with each other.” Co-founder and CEO of Affectiva, the category-defining MIT spinoff and pioneer of Emotion AI, el Kaliouby invented the company’s award-winning emotion recognition technology. Using large, diverse datasets – comprised of 8.8 million faces analyzed in 87 countries – to detect complex and nuanced emotions and cognitive states, the Emotion AI platform combines facial expression and tone of voice to infer how a person is feeling. Now, having advanced the technology beyond just emotions, el Kaliouby is pioneering Human Perception AI: software that analyzes face and voice to detect nuanced human emotions, complex cognitive states such as drowsiness and distraction, activities and objects people use. El Kaliouby has raised over $50 million in venture and strategic funding for Affectiva. Among other applications, the company’s technology is used by leading companies in the automotive industry to improve road safety and deliver better, more personalized transportation experiences. In addition, 25% of the Fortune Global 500 companies use Affectiva’s technology to test consumer engagements with ads, videos and TV programming. It is also used in healthcare, education, social robotics, conversational interfaces and more.
Teaching machines to measure and interpret human emotions has the potential to dramatically improve lives, with such powerful applications as assisting doctors and nurses in delivering better care, engaging students and personalizing their learning experience, and increasing road safety by making “emotionally aware” vehicles. It also promises to forever change the rules of consumer engagement by providing real-time insight into viewers’ emotional responses to brands, ads and other digital content. El Kaliouby’s work and research into new frontiers for AI technology are the subject of her upcoming book with Carol Colman, “Girl Decoded: A Scientist’s Quest to Reclaim Our Humanity By Bringing Emotional Intelligence to Technology” (Penguin Random House, April 2020).
A passionate advocate for innovation, ethics in AI and diversity, Dr. el Kaliouby was recently appointed an Executive Fellow at Harvard Business School where she will co-teach AI-related classes. As her popular TED talk made apparent, Dr. el Kaliouby has the ability to simplify and translate complex science, and make it accessible to any audience. Her credentials as a popular spokesperson for science led to her co-hosting the PBS Nova Series, “Nova Wonders,” which premiered in April 2018. A founder of her own technology company, an accomplished inventor, and one of few women to have successfully transitioned from academia to business, Dr. el Kaliouby – and her work – earn considerable recognition.
Named to the 2018 Thinkers50 Radar list of management thinkers most likely to shape the future of how organizations are managed and led; to Fortune’s 2018 40 Under 40 of the most influential young people in business; Forbes America’s Top 50 Women in Tech; Inc.’s Female Founders 100; Bostinno’s 50 on Fire; and WIRED’s 25 Geniuses Who Are Creating the Future of Business. Recently inducted into the Women in Engineering Hall of Fame, Dr. el Kaliouby is also a World Economic Forum (WEF) Young Global Leader and a newly minted Young Presidents’ Organization member. She is also often cited in and interviewed by top business and mainstream outlets, including The New Yorker, Wired, Forbes, Fast Company, The Wall Street Journal, The New York Times, TIME Magazine, Fortune, CNN, CBS and Reddit.
Prior to founding Affectiva, Dr. el Kaliouby was a research scientist at the MIT Media Lab where she spearheaded applications for facial coding to benefit mental health, autism and other research areas. Born and raised in Cairo, she received Bachelor of Science and Master of Science degrees in computer science from the American University in Cairo and a Ph.D. from the Computer Laboratory, University of Cambridge.
AI-based virtual assistants are evolving quickly. Now, increasingly more effort and resources are being put toward making them emotionally intelligent – able to pick up on subtle cues in speech, inflection, or gesture and expression to assess a person’s health and well-being. Nurse avatars and social robots – such as Catalia Health’s Mabu, an emotion-aware personal care companion for terminally ill patients – are already proving their abilities to enhance patient-centered health care environments around the world, making routine processes more efficient, and improving experiences and outcomes. But their full potential is even more profound and far from realized, believes Dr. Rana el Kaliouby.
Emotion AI, she says, provides an opportunity to transform numerous aspects of health and well-being, from telemedicine and drug efficacy to mental health research and autism support. By reading into a vocal tone or detecting facial expressions, for example, emotion AI-enabled platforms could detect depression or even potentially underlying chronic conditions, such as heart disease. In telemedicine, mood-aware wearables could contribute to monitoring mental health and well-being, perhaps helping those with depression track their emotional state and share that data with their doctor.
David B. Pryor, MD -
Former Executive Vice President and CMO, Ascension Health, Former President & Chief Executive Officer, Ascension Clinical Holdings
Former Executive Vice President and CMO, Ascension Health, Former President & Chief Executive Officer, Ascension Clinical Holdings
David B. Pryor, MD, is the former Executive Vice President, Ascension and President and CEO, Ascension Clinical Holdings, an Ascension subsidiary. In this role he supported the practices of the more than 40,000 physicians and caregivers and practice sites across Ascension Health, another Ascension subsidiary, to deliver improved care for populations of patients. From 2001 to 2011 he was the Chief Medical Officer of Ascension Health, the largest not-for-profit healthcare delivery system in the U.S. Prior to joining Ascension Health, Dr. Pryor was Senior Vice President and Chief Information Officer for Allina Health System in Minneapolis, Minn. Prior to Allina, Dr. Pryor was President of the New England Medical Center Hospitals in Boston, Mass. Dr. Pryor spent the first 15 years of his career at Duke University Medical Center in Durham, N.C., where he served as Director of the cardiology consultation service, the section of Clinical Epidemiology and Biostatistics, the Duke Database for Cardiovascular Disease, and clinical program development. Dr. Pryor graduated from the University of Michigan Medical School and did his medical training at Pennsylvania Hospital, and his cardiology fellowship at Duke University. Dr. Pryor has participated in numerous national and international committees. He has authored over 250 publications. In addition to his position at Ascension, Dr. Pryor’s academic appointments include Consulting Associate Professor of Medicine at Duke University Medical Center.
Brent C. James, MD, MStat -
Clinical Professor, Clinical Excellence Research Center (CERC), Department of Medicine, Stanford University School of Medicine
Clinical Professor, Clinical Excellence Research Center (CERC), Department of Medicine, Stanford University School of Medicine
Brent James is known internationally for his work in clinical quality improvement, patient safety, and the infrastructure that underlies successful improvement efforts, such as culture change, data systems, payment methods, and management roles.
He is a member of the National Academy of Medicine (formerly known as the Institute of Medicine), and participated in that organization’s seminal works on quality and patient safety.
He is a Clinical Professor at the Clinical Excellence Research Center (CERC), Department of Medicine, Stanford University School of Medicine.
He holds adjunct faculty appointments at several other universities:
Visiting Lecturer, Harvard School of Public Health (Health Policy and Management)
Adjunct Professor, University of Utah David Eccles School of Business
Adjunct Professor, University of Utah School of Medicine (Family Medicine; Biomedical Informatics)
He is a Fellow of the American College of Physician Executives.
He is presently a Senior Advisor at Health Catalyst, Salt Lake City, UT; Senior Fellow at the Institute for Healthcare Improvement (IHI), Boston, MA; and a Senior Advisor at the Leavitt Group, Salt Lake City, UT.
He is was formerly Chief Quality Officer, and Executive Director, Institute for Healthcare Delivery Research at Intermountain Healthcare, based in Salt Lake City, Utah.
Through the Intermountain Advanced Training Program in Clinical Practice Improvement (ATP), he has personally trained more than 5,000 senior physician, nursing, and administrative executives, drawn from around the world, in clinical management methods, with proven improvement results (and leading to over 50 “sister” training programs in more than 10 countries).
He currently anchors an upgraded version of the ATP, Mastering Clinical Quality / Leading Clinical Change (MCQ), based at Health Catalyst in Salt Lake City, UT.
He has been honored with a series of awards for quality in health care delivery, including (among many):
2018 John M. Eisenberg Patient Safety & Quality Individual Award, Joint Commission & National Quality Forum, March 2019
Distinguished Alumnus, University of Utah, 2015
Deming Cup – Columbia University School of Business, 2011
C. Jackson Grayson Medal, Distinguished Quality Pioneer – American Quality and Productivity Center, 2010
Joint Commission Ernest A. Codman Award, 2006
AHA HRET TRUST Award, 2005
National Committee for Quality Assurance (NCQA) Quality Award, 2005
American College of Medical Quality Founders’ Award, 1999
For 8 of first the 9 years it existed, he was named among Modern Physician’s “50 Most Influential Physician Executives in Healthcare.” He was named among the “100 Most Powerful People in Healthcare” (Modern Healthcare) for over 5 consecutive years, and among Modern Healthcare’s “25 Top Clinical Informaticists”.
Before coming to Utah in 1986, he was Assistant Professor in the Department of Biostatistics at the Harvard School of Public Health, providing statistical support for the Eastern Cooperative Oncology Group (ECOG) and Cancer & Leukemia, Group B (CALG); and staffed the American College of Surgeons’ Commission on Cancer.
He holds the following degrees; Bachelor of Science degrees in Computer Science (Electrical Engineering) and Medical Biology; an M.D. degree (with residency training in general surgery and oncology); and a Master of Statistics degree.
He serves on several non-profit boards of trustees dedicated to clinical improvement and patient safety.
Topic: Successful, Large-Scale Quality Improvement at Ascension
Good quality is good business. Ascension has demonstrated real change that happened on a dramatic scale across a system of systems. They have realized over $1 Billion of annual cost savings while working on improving quality. How did they achieve that? How does clinical change happen at the front line where it really matters? Dr. David Pryor will share his learnings over the years about how to achieve quality improvement that matters. He will discuss four critical points:
Focus on the innovators and early adopters
Capitalize on existing trends
Set the right goals
Work goals in the right way
Join Dr. Pryor and Brent James as they share learnings and best practices.
John holds a BS in human genetics along with an MS of Biomedical Informatics from the University of Utah school of medicine. For over 25 years, he has guided healthcare institutions and payers to turn data into actionable assets. John has led the development of analytic strategies for dozens of healthcare organizations and/or payers to optimize and elevate their analytic teams. He has designed and implemented hiring practices and career development tracks for hundreds of healthcare data analysts, data architects/engineers, and data scientists around the United States. John’s overarching passion is to help communities, healthcare institutions, and payers produce thriving analytic ecosystems to sustainably improve patient care.
What do you get when you combine rubber circles, x-ring metal segments, hub and spoke cylinders, hand levers, and highly flammable liquid? With the right combination of parts and expertise for functional design, the sum of the parts turns into something wholly novel: a Yamaha WR250f dirt bike.
Healthcare systems can benefit from a reconfiguration of data, tools, technology, and analytic skill to drive their organization into uncharted territory with confidence and agility. The result: data-driven, integrated systems of success.
Join us for another humorous, memorable, and insight-filled session where once again John Wadsworth uses a simple analogy to drive home salient points in how to systematize healthcare analytics.
In this session, you will:
Rethink your tech (and other) investments around the quadruple aim.
Better understand how to measure and derive value.
Increase appreciation for the power of analytic integration in healthcare delivery.
Amy Flaster, MD, MBA -
Chief Medical Officer, ConcertoCare; Associate Physician, Brigham and Women's Hospital; Instructor of Medicine, Part-Time, Harvard Medical School
Chief Medical Officer, ConcertoCare; Associate Physician, Brigham and Women's Hospital; Instructor of Medicine, Part-Time, Harvard Medical School
Amy Flaster, MD, MBA is a physician executive, value-based care strategist, and practicing internal medicine physician. Dr. Flaster has focused her career on leveraging clinical innovation, data, and technology to improve clinical outcomes, champion patient-centered care, and lower the cost of care. She is passionate about work at the intersection of population health, primary care, and digital innovation.
Prior to joining the ConcertoCare team, Amy served as the Senior Vice President for Population Health at Health Catalyst. There, she led a team that works with large integrated delivery systems, Accountable Care Organizations and Clinically Integrated Networks nationwide on their journey to alternative payment model adoption. She drove company-wide population health strategy and partnered with provider systems nationally to develop strategies for care delivery innovation, medical management, network expansion, and successful performance in ACO contracts.
In her role as Associate Medical Director of Population Health at Mass General Brigham (MGB), Amy ran population health programs to drive healthcare transformation across the network, including the nationally recognized Integrated Care Management Program (iCMP), leading a staff of over 200 clinicians in the provision of data-driven complex care management for frail and elderly patients. Prior to leading care management, she oversaw Employee Health at MGB, leading the population health and medical management of 75,000 employees enrolled in the self-insured health plan, and previously also oversaw Medicaid programming for the system, including creating and launching an ED Navigation program focused on vulnerable Medicaid patients that are frequent utilizers of the Emergency Departments. Prior to her work at MGB, she co-founded myProxy, Inc., which developed the TrueNorth Healthcare platform to engage patients and surrogate decision makers in advance care planning.
Amy continues to serve as an Instructor of Medicine, Part-Time at Harvard Medical School and practices primary care at Brigham and Women’s Hospital Advanced Primary Care Associates. Amy completed a BA from Dartmouth College, an MD at Harvard Medical School, and an MBA from Harvard Business School. She completed her residency in Internal Medicine in the Primary Care track at Brigham and Women’s Hospital and is board certified in Internal Medicine.
As new value-based care models continue to be released by Medicare and CMMI, the ecosystem of innovation in the space continues to grow. Learn about one model that is delivering novel, home-based care to Medicare patients through full risk value-based care contracts. By delivering in-home medical and behavioral care, enhanced by proprietary care pathways, advanced analytics, and virtual care technology, this model has shown where the next generation of care delivery models are headed. This presentation will also touch on other care providers and technology offerings in the space that are changing the lives of Medicare patients, improving their outcomes, and lowering the cost of their care.
Participants will discover:
The latest value-based care models being released by Medicare/CMMI.
How to best leverage analytics to optimize the outcomes of Medicare patients.
Lessons learned and how to apply them to your organization.
Executive Director, Revenue Integrity & CDM, MultiCare Health System
Nicole Gorder is the Executive Director of Revenue Integrity and CDM at MultiCare Health System. MultiCare is a Tacoma, Washington-based healthcare system comprised of 11 hospitals and more than 250 clinics. In her role, Nicole is accountable for providing governance structure and oversight to the system’s charge capture processes, policies, and adherence. Her department also has responsibility for the integrity of MultiCare’s charge codes and prices. In her 6 years at MultiCare, she has successfully overseen the acquisition and integration of four hospitals, hundreds of clinics, and several partnerships and joint ventures to ensure all chargemaster information, and resulting revenue, is appropriate and compliant.
Nicole has an undergraduate degree in business with an accounting concentration and an MBA with specialization in healthcare, both from the University of Washington. Her early career experience in accounting and finance partners well with her desire to continually strive for complete, accurate, and timely charge capture practices. As a patient and consumer, she also wants to provide highly reliable service, inclusive of billing practices, to all MultiCare’s past, current, and future patients.
With MultiCare’s significant growth in recent years, coupled with the industry’s changing reimbursement structure, Nicole is passionate about ensuring the organization has strong internal processes and procedures in place to secure owed revenue. With three years of experience as an EHR implementation and optimization consultant, she is further inspired to find best-practice system solutions for identified gross and net revenue opportunities. Nicole is a Pacific Northwest native who is excited by her upcoming relocation Tucson, Arizona, with her husband and two daughters.
Failure to improve charge capture integrity can lead to millions in revenue leakage, compliance issues, incorrect billing, and frustrated patients. MultiCare Health System’s executive director of revenue integrity and charge description master will share how the organization is using charge capture analytics solutions to meet its revenue integrity goals. This session will review how revenue reconciliation efforts, workflow redesign, and audits result in the rapid identification and resolution of charge capture errors, ensuring compliance and accelerating revenue recognition.
Participants will learn:
How to leverage analytics to build a robust charge audit program.
How to detect and remedy charge compliance issues.
Innovations Lead, Predictive Analytics and Applications Development, Texas Children's Hospital
Jaclyn manages the Innovations Team at Texas Children's Hospital. Under her leadership, the team develops and deploys predictive analytics solutions and does custom application development. With experience spanning the vendor, consultant, and enterprise IT spaces, Jaclyn considers herself to be an "IT generalist" whose emphasis on People, Process, Technology, and Culture enables digital transformation across contexts. She has been with Texas Children's for seven years; prior to her current role with Innovations, she worked on various strategic initiatives across the Business Intelligence, Epic, and Clinical Applications spaces. Jaclyn's hobbies include backcountry camping, scuba diving, rock climbing, and experimenting in the kitchen.
Assistant Director, Care Coordination, Texas Children’s Hospital
Lisa leads the Inpatient Care Coordinators at Texas Children’s Hospital. This team assists in ensuring timely discharges from the hospital and coordinating all post-acute care discharge needs for patients and their families. Lisa’s leadership experience includes Women’s and Children’s services, Quality and Compliance, Solid Organ Transplant, and Care Coordination. Her hobbies include scuba diving, working in the yard, working on her doctoral nursing degree, and spending time with family and friends.
A good predictive model alone won’t yield real-world outcomes. To achieve results, organizations must pair predictive models with effective interventions and delivery tools. In this session, representatives from Texas Children’s Hospital, the largest pediatric hospital in the U.S., will describe a framework for effective predictive model implementation in clinical practice, featuring the organization’s custom Pediatric Readmissions model. By accurately flagging 20 percent of patients as potential readmissions, Texas Children’s was able to apply early interventions and reduce potential readmissions by 5 percent.
Participants will learn:
The value predictive models add to clinical decision making.
The tools and interventions needed to maximize predictive models.
How to effectively implement predictive models in clinical practice.
Assistant Director, Business Operations and Strategic Planning, Texas Children’s Hospital
Grace Karon is the Assistant Director of Business Operations and Strategic Planning at Texas Children’s, with scope including practice management data integrity. With a background working in defense and manufacturing startups, Grace brings experience in long-term strategic planning, financial modeling, and marketing to Texas Children’s. Grace has a BS in Economics.
Carrie Rys is the Assistant Vice President of Pediatrics Administration at Texas Children’s Hospital. Carrie has been with Texas Children’s for 20 years. During this time, she spent 10 years as a Director leading teams responsible for TCH and TCPSO Revenue Cycle Operations. In her current role, Carrie’s responsibilities include executive leadership of practice administration associated with 20 Pediatric Medical Sub-specialties. Carrie also has responsibility for the Centralized Credentialing Unit, including both hospital and payor credentialing activities. Carrie has a BBA in Finance as well as an MBA in Accounting.
Facing unprecedented challenges related to the COVID pandemic, Texas Children’s Hospital leveraged patient-facing technology to pivot to a new definition of patient access. Discover how Texas Children’s enhanced the digital patient experience and journey, fostered a zero-touch care environment and ensured continuity of care across various care settings.
This session will detail the people, processes, and technology changes that led to:
More than 100K appointments scheduled online.
68K unique patients with telemedicine visits.
An 8% increase in patient satisfaction.
Nearly $1M in cost savings.
Participants will learn:
What strategies are used to identify digital technology opportunities.
How to address internal and external change management concerns to drive adoption of new digital technologies.
How to ensure continuity of safe, high-quality patient care through virtual technology and in-clinic enhancements.
Director, Clinical Data and Analytics, ChristianaCare
Dr. Edward Ewen is Director of Clinical Data and Analytics for Christiana Care Health System. He leads his organization’s enterprise information management program and is responsible for coordinating and setting strategies for its data warehousing, data governance, and business analytics activities. He has over 25 years’ experience in health care data warehousing and analytics. He is board certified in both Clinical Informatics and Internal Medicine with over 30 years of clinical practice in both primary care and hospitalist medicine.
Dr. Wei Liu is a data scientist at ChristianaCare, Delaware, one of the largest health systems nationwide. She is leading the enterprise's advance analytic efforts with a focus on developing data mining and machine learning models for patient risk stratification, clinical decision support, population health management, and health equity evaluation. Prior to joining Christiana Care, Wei worked as a Senior Data Analyst at Children’s Hospital of Philadelphia (CHOP), where she conducted advanced data analytics to support decision making of hospital operation and patient flow, and as an Industrial Engineer at MD Anderson Cancer Center focused on process optimization and quality improvement. Wei holds a Master of Science in Health Systems from Georgia Institute of Technology in 2009 and Ph.D. in Industrial Engineering from Purdue University in 2017. Wei has a great passion for promoting quality and efficiency in a healthcare system with a special interest in using data-driven approaches to support decision making.
With limited resources and rapidly growing COVID-19 patient volumes, accurate and rapid identification of individuals at the highest risk of hospitalization is a top priority. To identify and target interventions towards high-risk patients, ChristianaCare leveraged a cloud-based data platform and analytics applications, including data science tools and predictive analytics, to generate a risk score for each patient testing positive for COVID-19. Join this session to learn how up-to-date risk identification helped the organization make data-informed resource allocation decisions and enroll patients in the appropriate care management program, avoiding 61 hospital admissions and 7 intensive care unit admissions and avoiding $1.8 million in cost.
Participants will learn:
What risk prediction tools were used.
How up-to-date risk identification helped the organization make timely, data-informed decisions.
What interventions were used to avoid hospital and ICU admissions.
Strategic Advisor, Former Executive Vice President and Chief Financial Officer, UPMC
Rob is the retired Executive Vice President and Chief Financial Officer of UPMC, a $20B+ nonprofit health system and leading health care provider and insurer. During his time at UPMC, Rob implemented best practices in controllership, with UPMC achieving voluntary SOX 404 certification in 2006. He also led UPMC’s activity-based costing/service-line implementation and Consumerism initiatives. In addition to Finance, Rob led the Supply Chain Management and Revenue Cycle functions, driving integration, technology infusion, and process improvement/efficiency throughout the organization. Rob’s teams created a number of healthcare technology solutions, three of which were commercialized and spun-off.
Before his 16- year tenure at UPMC, DeMichiei held various executive roles with the General Electric Company (GE) and Price Waterhouse in Pittsburgh. Rob currently serves on the Board of Directors of Waystar, where he is the Audit Committee Chair. He also serves as the Board Chair of the United Way of Southwestern Pennsylvania, Investment Committee Chair of AAA East Central, and Finance Committee Chair of the Seton Hill University Board of Trustees. Rob also serves as a Strategic Advisor for Health Catalyst (NASDAQ; HCAT). Rob has a BA in Business Economics from the University of Pittsburgh.
Jared has been serving as the Chief Financial Officer for UPMC Presbyterian Shadyside Hospital since 2016. He has been with UPMC since 2008 working in various finance roles. He also serves as a Board Member and Finance Committee Member for Bethlehem Haven, a homeless shelter in Pittsburgh, and a therapy dog handler for Therapy Dogs International. Jared received a Master's and Bachelor of Business Administration from the University of Pittsburgh.
To effectively manage cost, healthcare leaders need the right data, provided to the right people, at the right time. UPMC first integrated patient- and physician-level analytics to gain better insight into operating costs and clinical variation across its provider footprint. More recently, they assessed their existing labor budget and productivity system, a decades-old, homegrown tool with outdated functionality and limited reporting on FTEs. Recognizing the opportunity for an improved solution, UPMC launched integrated department- and leader-level labor budget and productivity analytics, putting invaluable staffing and productivity information into the hands of operational leaders across its many hospitals.
Goals of this session:
Understand the current challenges facing providers, including horizontal competition from large insurers and digital disrupters, headwinds from price transparency, and growth in managed care programs, like Medicare Advantage.
Introduce a new approach to cost transformation, utilizing existing EHR data to create patient- and physician-level costing, and measuring clinicians based on value and the “Triple Aim.”
Identify the elements of an effective labor budgeting and productivity solution, including key functionality for finance and operational users.
Describe how data at the right grain increases the accuracy of analytics—and results in actionable improvements.
Articulate the keys to success for labor analytics, including in-depth analysis of historical operations and staffing, consistent training and documentation, and engagement of key operating teams across the organization.
Vice President, Clinical and Business Intelligence, Carle Health
Phillip currently serves as the vice president of clinical and business intelligence. Based in Urbana, IL, Carle Health is a vertically integrated system with more than 11,500 employees in its five hospitals, multi-specialty physician groups, health plans, and associated healthcare businesses including the Carle Illinois College of Medicine, the world’s first engineering-based medical school.
As a senior health administration executive, he is responsible for the procurement and analysis of data to support the health system. His team enables advanced data analytics, facilitates clinical quality initiatives, supports financial analysis, advances clinical research studies, and provides data for key business and market decisions.
Prior to joining the leadership team at Carle, he worked as a director in PriceWaterhouseCoopers’ global healthcare practice, where he worked with and advised health plans, providers, and government associations. Phil has also held leadership roles at Cerner Corporation and brings a depth of business analytics, solution architecture, and IT project management experience. Phil has led and supported over 40 projects, across 11 countries, on four continents to support clinical transformation and patient care.
A Champaign native and graduate of University Laboratory High School, Rowell received his Master of Jurisprudence in Health Law and Bachelor of Business Administration from Loyola University. Mr. Rowell is also an adjunct professor of legal issues in healthcare information technology, and healthcare policy and ethics in the graduate school of Health Professions at Sacred Heart University.
Data governance often has negative connotations, such as contention, complexity, or tedium. In addition, the challenges associated with effective data governance, including breaking down long-existing data silos, a lack of trust in the data, and executive buy-in, can further thwart progress. There are, however, better ways to perform healthcare data governance. Join this session to learn how proven approaches and a shared vision for data governance allow health systems to maximize data, their greatest asset.
Participants will learn:
The common pitfalls of data governance and how to address them.
How to use the momentum from the data procurement stage to develop an effective data governance strategy.
The positive results health systems can achieve from effective data governance.
Vice President, Performance Improvement, The University of Kansas Health System
Jack Beal serves as the Vice President of Performance Improvement at the University of Kansas Health System, based in Kansas City, Kansas. In this role, he has responsibility for process, performance, and quality improvement work, the development, and deployment of the System’s improvement and management systems applied analytics, clinical variation reduction programs, and clinical and operational redesign across the inpatient and ambulatory enterprises. Jack is also Deputy General Counsel for the health system, providing leadership with respect to all legal and regulatory matters.
Jack completed his undergraduate at William Jewell College and a law degree at the University of Tulsa with the highest honors. Previously, Jack was a Shareholder at Polsinelli PC, where he practiced in the areas of health care and corporate law. While in private practice, his work included advisement on contracting and compliance needs. Jack also has significant experience with health care merger and acquisition transactions, with a focus on the structure, development, and negotiation of innovative arrangements to align and improve the quality and cost effectiveness of care in numerous settings.
Director, Applied Analytics and Business Intelligence, The University of Kansas Health System
Maks Ovsiyenko is a Director of Applied Analytics and Business Intelligence at The University of Kansas Health System. He is leading the enterprise’s analytical efforts with a focus on transforming data into actionable information to support clinical, financial, operational, and strategic decision-making processes. Maks started his career with the health system on the strategy side of operations developing methods to improve strategy deployment and understanding its impact in a quantitative manner, before taking on a broader analytical leadership role.
Maks has an undergraduate degree in Business Administration from LCC International University and two master’s degrees from Park University (MBA and MHA). With over 11 years of experience in a healthcare industry, Maks is continually working with his teams to deliver meaningful information to the enterprise in the most efficient and effective manner.
While The University of Kansas Health System embarked on its data transformation journey in 2014, the health system needed to better leverage its data platform, analytics tools, and team to more rapidly improve their performance and the quality and speed of decision making in the organization. Specific objectives included understanding and improving the organization’s performance in safety, quality, effectiveness, efficiency, equity, access, and patient experience. Over three fiscal years, the organization has observed quality improvements in many areas, including a 0.69 O/E mortality rate for patients admitted to the hospital, $2.3 million in savings by reducing readmission rates, a 22.5 percent reduction in clostridioides difficile, and a 26 percent reduction in initial denials.
Participants will learn:
How to improve the use of data and analytics.
How to push data to the bleeding edges of the organization to achieve revenue, cost, and quality improvements.
What tools, resources, and data team skills were used to achieve their improvement goals.
Chief Medical Officer, Health Alliance Medical Plans; Population Health, Carle Health
Dr. Chester (Chet) Ho joined Health Alliance in 2020 as the physician executive overseeing the Health Alliance and Carle HealthPopulation Health services model focusing on predictive and actionable analytics, care management, quality improvement, risk adjustment, physician/provider engagement, user interfaces, and value-based payment strategies.
Dr. Ho has over 20 years of physician executive experience in the provider, payer, and healthcare management consulting areas. His previous experience on the provider side includes multi-specialty physician group leadership, practice and hospital operations, recruiting, physician/provider compensation, and population health model design. Dr. Ho also has health plan experience as a UM medical director and Chief Medical Officer. Most recently, Dr. Ho spent 7 years at Evolent Health, a national healthcare management company, as Chief Medical Officer overseeing clinical, quality, and value-based provider performance services for Evolent’s national provider partners with ACOs, Medicaid, and Medicare Advantage health plans.
Dr. Ho is a Board Certified Pediatrician who received his Medical Degree from The University of Chicago Pritzker School of Medicine and has done leadership coursework in business, finance, quality, and managing physician performance through the American Association of Physician Leadership (formerly the American College of Physician Executives).
Senior Vice President and Chief Clinical Integration Officer, Health Alliance Medical Plans and Carle Health
April Vogelsang, RN, MS, currently serves as the System Senior Vice President & Chief Clinical Integration Officer at Health Alliance Medical Plans & Carle Health, having worked in the Carle system since 2006. She has provided progressive healthcare and health services leadership experience since 1996, with expertise in government business, matrix management, interdisciplinary project management, and aligning operational tactics with strategic initiatives. She provides strategic and operational oversight for integrated enterprise strategy for Population Health and Health Alliance Clinical Operations (Case Management, Population Health, Health Coaching and Prevention/Wellness, Utilization Management, Quality Services, Pharmacy, and Risk Adjustment Solutions), including the Stratum Med Accountable Care Organization (ACO).
She holds a Master of Science in Health Services Administration, and is a member of the American College of Healthcare Executives (ACHE), America’s Health Insurance Plans (AHIP), the Alliance of Community Health Plans (ACHP) and Illinois Organization of Nurse Leaders. Additionally she serves on the Board of Directors for CIMRO and Great Plains Quality Innovation Network. She has contributed to local and national publications (Journal of Managed Care Nursing) and presented at numerous national conferences.
Hidden opportunities can be found among health systems and other risk-bearing entities to improve the quality and decrease the costs of providing healthcare to at-risk patient populations. Discover how Health Alliance, a vertically integrated health system with a health plan and population health organization, found and maximized these opportunities by breaking down the barriers between entities to accomplish two fundamental goals:
Implement a system-wide structure to manage sustainable population health efforts.
Develop and implement a population health care model that improves the quality and reduces costs associated with a fully at-risk (capitated) population.
Early reviews of the population data, even accounting for the impact of COVID-19, show a 30 to 40% reduction in ED utilization and 27% decrease in readmissions. Data supports a 2.8:1 return on investment.
Participants will learn:
Where population health staff must be embedded to make the biggest difference.
What goals matter most when creating scalable population health programs.
How program value can be proven even during utilization changes (such as those caused by COVID).
Holly Fetter is a Business Analyst who works at Albany Medical Center in Albany, New York. For the past 4 years, she has worked on database management in the healthcare industry with her strong background in data science and statistical analytics. Holly holds a Bachelor’s degree in Library and Information Science from the University of Maine and a Master’s degree in Data Science and Computational Biology from Lewis University.
Medical claims denials occur for myriad reasons – from a lack of supporting documentation to patient ineligibility under the billed insurance plan. Another significant factor is the lack of integrated data, which makes root cause analysis of denials extremely difficult and time-consuming on already heavily taxed finance resources. Denials result in delayed collections, increased administrative burden, and millions in lost revenue annually.
Join Albany Medical Center’s ReClaim Squad to learn how they are using their data platform and analytic applications to quickly identify and rectify denial issues, ensuring maximum reimbursement. The ReClaim Squad has managed 149 claims denial cases and recovered nearly $3M in revenue in just one year.
Participants will learn:
What comprises the visit to claims payment cycle.
How to integrate data and analytics into denials manage management projects.
How integrating data into the workflow can improve revenue cycle performance.
General Manager & Senior Vice President, Life Sciences Business, Health Catalyst
Sadiqa Mahmood, DDS, MPH is the Senior Vice President and General Manager of the Life Sciences business at Health Catalyst and contributes to the overall vision and growth for the company. Sadiqa’s work focuses on identifying and addressing areas of high unmet need for therapeutic development through application of real-world data. She is an advisor to several healthcare organizations and global policy makers. Sadiqa is a dental surgeon and holds a master’s degree in public health from the Harvard School of Public Health.
Passionate about improving access to care and patient outcomes by leveraging data and healthcare ecosystem, Sadiqa has spent her career at the intersection of medicine, policy, technology, and analytics. Previously she led clinical analytics, quality and safety, value-based contracting, and population health across healthcare organizations, including the Dana-Farber Cancer Institute, Partners HealthCare System, and Boston Medical Center. Sadiqa has been an advocate of collaborative learning system in healthcare and has steered cross-industry multi-stakeholder national and global collaborations to drive healthcare innovation.
She joined Health Catalyst in 2019 as SVP of Medical Affairs. Sadiqa has lived and worked in Asia and UK in addition to the US. She is based in Boston, Massachusetts. Outside of work, she is a Formula 1 fan and races as a member of a local team.
Based in Washington DC, Dr. Qin Ye is the Global RWE lead for ZS. Qin joined ZS in 2016, where he has been focusing on helping clients realize the value of their RWD investment through our strategy, data science, and technology capabilities. In his role, Qin leads the development of our RWE team, oversees the development of our RWE technology, and works directly with clients on evidence generation and advanced data sciences programs across clinical, HEOR, medical, and market access functions.
As a trained physician, outcome researcher, and data scientist, Qin has over 20 years of health informatics and data analytics experience with in-depth knowledge of medical terminologies, data standards, prospective RWE registries, and various EHR products, pragmatics trials designs, observational study methods, and health economics.
Qin has a distinctive combination of health informatics, life science data analytics, and leadership experiences across the healthcare industry. These include Director, Health Informatics at AstraZeneca where he leads the development of global and cross-functional RWE technology and analytics capabilities; Chief Medical Informatics Officer at Acupera; Executive VP at Medversant Technologies; Associate Medical Director at Pfizer; and Principle Architect at IDX Systems Corp.
Qin holds a medical degree from the School of Medicine, Beijing University, and a Master’s degree in Health Informatics & Outcomes Research from Oregon Health & Science University.
Providers and pharma have traditionally looked at each other as transactional partners, but that is all changing. There is a new spectrum of opportunities available with what providers already do every day to enhance the quality of care, improve operational outcomes, and drive innovation. Hospital systems are currently the most stressed healthcare pillar—providers are feeling the effects of COVID-19 across outcomes, patient experience, finances, and the well-being of the care team. Many challenges are shared between providers and pharma. The pandemic has solidified the need for a strategic long-term partnership to solve these common challenges by building bridges between providers and pharma through data, technology, and shared expertise.
Sr. Director of Data Quality & Operations, Data Business Unit, Health Catalyst
Taylor Larsen is the Sr. Director of Data Quality and Operations for the Data Business Unit at Health Catalyst where his team is building solutions that leverage data science, cross-client comparisons, and embedded subject matter expertise to assess, demonstrate, improve, and monitor healthcare data quality and processing performance to facilitate better and more reliable data-informed decision making.
Taylor is operationalizing a vision for data quality at Health Catalyst that systematizes a shift from structural and content-focused data quality to data quality defined by the measurable utility and insists data quality improvement is prioritized within the context of outcomes improvement governance. Taylor earned his master's degree in economics from the University of Colorado and his professional experience includes time with Health Catalyst’s Data Science team and at Colorado Medicaid, which provides a unique perspective to draw from in his data quality work.
Healthcare organizations increasingly rely on data to inform strategic decisions. This growing dependence makes ensuring data across the organization is fit for purpose more critical than ever. Decision-making challenges associated with pandemic-driven urgency, variety of data, and lack of resources have further highlighted the critical importance of healthcare data quality and prompted more focus and investment. However, many data quality initiatives are too narrow in focus and reactive in nature or take longer than expected to demonstrate value. In this session, you’ll learn actionable ways to help your organization guard against the data quality challenges uncovered this past year and be better prepared to respond in the future.
Participants will learn:
How data profiling and data quality assessments can increase data quality transparency, expedite root cause analysis, and close data quality monitoring gaps.
How to leverage AI to reduce data quality monitoring configuration and maintenance time and improve accuracy.
How defining data quality based on its measurable utility can provide a scalable way to ensure data are fit for purpose and avoid cost outstripping return.
Executive Director of Care Management, UnityPoint Health
Kristin began her nursing career at UnityPoint 15 years ago as a frontline Orthopedics nurse. Advancing through leadership positions with Inpatient Nursing teams and moving to a continuum Orthopedic leadership position to lead the Service Line. During that time frame, Kristin also worked in an ‘as-needed’ role for The Joint Commission as a Disease-Specific Total Joint and Spine Surveyor. She spent the next two years working as an Operations leader in the Clinic setting with UnityPoint Clinic and then moved into the Population Health role as the Executive Director in 2019. Kristin has partnered with teams such as Analytics to move in step with the Care Teams toward reducing utilization for patients with the Care Teams. This partnered success is a team effort and a pride point of the Care Management program.
Executive Director of Strategic Analytics, UnityPoint Health
Rhiannon Harms is the Executive Director of Strategic Analytics at UnityPoint Health, a $4B, multi-state, integrated delivery system located in Iowa, Illinois, and Wisconsin. Her passion for using data to improve care quality, efficiency, and experience has led UnityPoint’s analytics maturity. Her work focuses on partnering with clinical and business leadership to solve today’s healthcare challenges. As a nationally recognized outcomes improvement leader, Harms and her team have received multiple awards including the Creative Tech Solution of the Year from the Technology Association of Iowa, the Innovator Award from Healthcare Informatics, and as a finalist for the ANNY Award from the International Institute for Analytics.
Navigating healthcare can be chaotic and challenging for patients with complex needs, necessitating effective care management to provide quality care and manage the costs associated with patients searching and receiving the care they need. Learn how UnityPoint Health continuously sharpens its focus on care management using AI and analytics. The organization leverages a unified, reusable data source that empowers care managers to easily identify and engage with the right patients at the right time. The results are improved patient experience, reduced inpatient admissions and emergency department visits, and a $32M reduction in healthcare spending, the result of decreased utilization.
Participants will learn:
How to best use predictive models to identify high-risk patients.
How to determine the probability of admission.
What tools can be used to provide cross-continuum patient and family support, decreasing unnecessary utilization.
Tom Burton co-founded Health Catalyst in 2008 and has served in many roles at Health Catalyst, including SVP of product Development, Chief Improvement Officer, President of Professional Services, Chief Learning Officer, and his favorite role as the Chief Fun Officer. He currently serves as a Strategic Advisor to Health Catalyst.
His leadership and decades of experience in business intelligence, analytics, learning science, and quality improvement have helped many care delivery systems significantly improve clinical, operational, and financial outcomes. Tom was part of the team that led Intermountain Healthcare’s nationally recognized improvements in quality and reductions in cost.
He founded Health Catalyst University and currently teaches courses in population health, data governance, leadership, and care delivery waste reduction. He has taught courses on the Toyota Production System, Agile Software Development, value-based care, and data system design at various institutes, including Intermountain Healthcare’s Institute for Health Care Delivery Research and Stanford’s Clinical Effectiveness Leadership Training.
He has presented numerous times at national conferences such as the Healthcare Analytics Summit and HIMSS. Tom holds an MBA and a BS in Computer Science from Brigham Young University.
Don’t miss this notable healthcare improvement and financial success edition of Jeopardy with host Tom Burton (a distant cousin of Alex Trebek). In this game show breakout session, Tom will test three lucky contestants’ knowledge of five key transformations vital to thriving with lower patient volumes in the post-COVID-19 era. If you’ve ever had the pleasure of attending one of Tom’s breakout sessions in the past, you know you’re in for an interactive, fun experience! Come to learn and be entertained.
Participants will learn:
What the five key transformations are to ensure post-COVID-19 success.
How analytics plays a crucial role in each of the five key transformations.
How health systems can succeed financially by fully adopting quality improvement in all parts of their organization as a business strategy.
Vice President, Real World Insights & Evidence, Health Catalyst
Nancy D. Lin, Vice President -Real World Insights & Evidence, joined Health Catalyst Life Sciences in September 2020. Dr. Lin is an epidemiologist with over 15 years of experience in clinical and pharmacoepidemiology research and specific experience in cross-institutional studies. Her primary research interests include application, utility, and methodologic considerations for the use of electronic health care data systems to enhance surveillance and assessment of medical products' safety and effectiveness. Prior to joining Health Catalyst, Dr. Lin was a Senior Scientist in the Optum Insight Life Sciences, Epidemiology business. In that capacity, she provided scientific oversight over a range of retrospective and prospective cohort studies that leveraged health care claims, electronic health records, and data linkages (e.g., medical records, free-text clinical notes, registry data), and from 2013-2020, served as Optum’s Site Principal Investigator supporting the FDA Mini-Sentinel/Sentinel initiative. Dr. Lin also serves as Chair of the Science Committee for the Biologics and Biosimilars Collective Intelligence Consortium, a non-profit, multi-stakeholder scientific initiative engaged in real-world evidence generation on the utilization, safety, and effectiveness of biologics and biosimilars using a distributed network of health care organizations. Dr. Lin received a Doctor of Science in Epidemiology in 2004 and a Master of Science in Epidemiology in 2001 from the Harvard School of Public Health.
Director of Research, Reagan-Udall Foundation for the Food and Drug Administration
Dr. Carla Rodriguez-Watson is the Director of Research at the Reagan-Udall Foundation for the FDA. The Foundation is an independent non-profit established by Congress to support FDA’s mission to modernize product development, accelerate innovation, and enhance product safety. Research programs cultivate and leverage public-private partnership and network studies to accelerate and improve real-world evidence generation for risk/benefit assessment of medical products.
Dr. Rodriguez-Watson, an infectious disease epidemiologist by training, has more than 23 years of experience with research using real-world data to examine health outcomes and comparative effectiveness, and in developing and evaluating public health surveillance systems. Her experience spans from Kaiser Permanente Research and the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS), where she focused on the use of health care transaction data (from claims and the EHR) in epidemiologic studies of HIV, viral hepatitis, liver and kidney disease; to the health departments of New York City, San Francisco, and Seattle & King County where she focused on developing and testing the accuracy of syndromic surveillance systems to identify outbreaks of specific disease.
Dr. Rodriguez-Watson earned her PhD in Epidemiology from the University of Washington School of Public Health; her MPH from Columbia University Mailman School of Public Health; and her BA from Rutgers University.
COVID-19 has made urgent the need for rapid evidence generation around disease understanding, testing, and treatment patterns in broad populations. In response, the Reagan-Udall Foundation for the FDA and Friends of Cancer Research developed the COVID-19 Evidence Accelerator to convene a real-world data healthcare ecosystem. This session will feature case examples from the Reagan Udall Foundation Evidence Accelerator and demonstrate the importance of a national data repository in driving real-world evidence generation to support multistakeholder collaboration.
Participants will learn:
How healthcare organizations, public health, and research can effectively collaborate.
How to design and execute an optimal process to incorporate a risk prediction model into operation.
How an optimal data structure and user-friendly visualization design can greatly improve model development and utilization.
Register Now
"This is the best conference I’ve ever been to in all my years in healthcare…and that’s over 20 years."
Everything was great and well thought out. From the gift packages with swag to the virtual games, it was fun and amazing!
This was a wonderful summit. So much valuable information that will be passed on at my organization.
This set the standard for what I will now expect from future virtual summits/conferences/educational experiences. Great job.
I think this event should be a model for how to hold a virtual conference. The live conference is a must-attend for my team, and the virtual version has lived up to the same standards.
The virtual experience was beyond any other that I’ve attended. You all did a wonderful job of creating an “in-person” feel and I appreciate that as a learner. The virtual platform was very intuitive and fun.
Unfortunately your web browser is out of date. For improved security, speed and the best experience please consider using the latest version of on the following browsers: Google Chrome, Firefox, Edge, Safari, or Opera.
This site uses cookies
We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.
